News

Welcome to Brainwork

899 506 Prof. Dr. Krassen Nedeltchev

Dear colleagues, Thank you for subscribing to BRAINWORK! Your participation has made our eLearning initiative stronger and more wide-ranging! What is Brainwork? Brainwork is a new online platform that aims…

read more
welcome-to-brainwork-ectrims-2017

ECTRIMS-ACTRIMS: OBOE study explores biomarkers of neurodegeneration and inflammation in multiple sclerosis

1920 1080 Peter Stevenson, PhD

The development and characterisation of biomarkers in multiple sclerosis (MS) could be a crucial step in understanding disease pathways, as well as the therapeutic mechanisms of disease-modifying treatments. So was…

read more
Brainwork-DiabeticDrugMayBenefitHigh-RiskStrokePatients

​Diabetes drug may benefit high-risk stroke patients

4064 2710 Camilla Norrmén, PhD

A study showed last year that the insulin-sensitizing drug pioglitazone reduces the risk for stroke in patients with recent ischemic strokes. A new secondary analysis of the trial results found…

read more
Brainwork-NavigateESUS

​NAVIGATE ESUS: Rivaroxaban vs aspirin study terminated due to comparable efficacy

2992 2000 Peter Stevenson, PhD

Early discontinuation has been announced for the Phase III NAVIGATE ESUS study – led by Bayer AG and its development partner Janssen Research & Development, LLC – which had been…

read more
Brainwork is supported by unrestricted grants from: